![Technology Showcase: Investigation into the Feasibility of a 2 mL Needle-Free Injector - ONdrugDelivery Technology Showcase: Investigation into the Feasibility of a 2 mL Needle-Free Injector - ONdrugDelivery](https://www.ondrugdelivery.com/wp-content/uploads/2022/10/138_2022_Oct_Portal_Figure_3-1024x791.png)
Technology Showcase: Investigation into the Feasibility of a 2 mL Needle-Free Injector - ONdrugDelivery
![Startup's needle-free drug injector gets commercialization deal | MIT News | Massachusetts Institute of Technology Startup's needle-free drug injector gets commercialization deal | MIT News | Massachusetts Institute of Technology](https://news.mit.edu/sites/default/files/images/201712/MIT-Portal-Instruments-A1.jpg)
Startup's needle-free drug injector gets commercialization deal | MIT News | Massachusetts Institute of Technology
![Technology Showcase: Investigation into the Feasibility of a 2 mL Needle-Free Injector - ONdrugDelivery Technology Showcase: Investigation into the Feasibility of a 2 mL Needle-Free Injector - ONdrugDelivery](https://www.ondrugdelivery.com/wp-content/uploads/2022/10/138_Oct2022_Portal_fig1.png)
Technology Showcase: Investigation into the Feasibility of a 2 mL Needle-Free Injector - ONdrugDelivery
![Startup's needle-free drug injector gets commercialization deal | MIT News | Massachusetts Institute of Technology Startup's needle-free drug injector gets commercialization deal | MIT News | Massachusetts Institute of Technology](https://news.mit.edu/sites/default/files/download/201712/MIT-Portal-Instruments-02.jpg)
Startup's needle-free drug injector gets commercialization deal | MIT News | Massachusetts Institute of Technology
![Takeda, Portal Instruments ink $100m deal to combine biologics and needle-free drug delivery - Drug Delivery Business Takeda, Portal Instruments ink $100m deal to combine biologics and needle-free drug delivery - Drug Delivery Business](https://www.drugdeliverybusiness.com/wp-content/uploads/2017/11/takeda-portal-large.png)
Takeda, Portal Instruments ink $100m deal to combine biologics and needle-free drug delivery - Drug Delivery Business
![Portal Instruments Selects CAP-XX Supercaps for Needle-Free Jet Injection Platform - CAP-XX Designs & Manufactures the Thinnest, Highest Power Density Supercapacitors & Ultracapacitors Portal Instruments Selects CAP-XX Supercaps for Needle-Free Jet Injection Platform - CAP-XX Designs & Manufactures the Thinnest, Highest Power Density Supercapacitors & Ultracapacitors](https://www.cap-xx.com/wp-content/uploads/2021/03/Portal-Instruments-Picture-4.jpg)